96,853 XNAS Volume
XNAS 28 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Shane J. Schaffer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 70,489 | 70,489 | - | - | Stock Option (right to Buy) | |
| Laurie A. Myers | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 17,630 | 17,630 | - | - | Stock Option (right to Buy) | |
| Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 17,630 | 17,630 | - | - | Stock Option (right to Buy) | |
| Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 17,630 | 17,630 | - | - | Stock Option (right to Buy) | |
| Jennifer L. Callahan | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 21,140 | 21,140 | - | - | Stock Option (right to Buy) | |
| Shane J. Schaffer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 27,638 | 27,638 | - | - | Stock Option (right to Buy) | |
| Laurie A. Myers | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 9,319 | 9,319 | - | - | Stock Option (right to Buy) | |
| Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 2,748 | 2,748 | - | - | Stock Option (right to Buy) | |
| Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 2,748 | 2,748 | - | - | Stock Option (right to Buy) | |
| Jennifer L. Callahan | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 11,539 | 11,539 | - | - | Stock Option (right to Buy) | |
| Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Laurie A. Myers | EVP and COO | Sale of securities on an exchange or to another person at price $ 4.16 per share. | 15 Aug 2024 | 202 | 0 | - | 4.2 | 841 | Common Stock |
| Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| John A. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (right to Buy) | |
| John A. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (right to Buy) | |
| John A. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 14,750 | 14,750 | - | - | Stock Option (right to Buy) | |
| Jeffrey S. Ervin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 13,875 | 13,875 | - | - | Stock Option (right to Buy) | |
| Jeffrey S. Ervin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (right to Buy) | |
| Jeffrey S. Ervin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (right to Buy) | |
| Shane J. Schaffer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 217,677 | 217,677 | - | - | Stock Option (right to Buy) | |
| Laurie A. Myers | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 98,944 | 98,944 | - | - | Stock Option (right to Buy) | |
| Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 63,324 | 63,324 | - | - | Stock Option (right to Buy) | |
| Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 63,324 | 63,324 | - | - | Stock Option (right to Buy) | |
| Peter J. Werth | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (right to Buy) | |
| Peter J. Werth | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 6,926 | 6,926 | - | - | Stock Option (right to Buy) | |
| Jennifer L. Callahan | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 94,986 | 94,986 | - | - | Stock Option (right to Buy) | |
| Bryan Lawrence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 14,125 | 14,125 | - | - | Stock Option (right to Buy) | |
| Bryan Lawrence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (right to Buy) | |
| Bryan Lawrence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (right to Buy) | |
| Peter J. Werth | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 341,912 | 481,829 | - | 0.0 | 684 | Common Stock |
| Peter J. Werth | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 694,096 | 0 | - | - | Pre-Funded Warrant (right to buy) | |
| Peter J. Werth | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 341,912 | 0 | - | - | Pre-Funded Warrant (right to buy) | |
| Peter J. Werth | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 694,096 | 1,175,925 | - | 0.0 | 69 | Common Stock |
| Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Peter J. Werth | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 25 Mar 2024 | 7,053 | 694,096 | - | - | Pre-Funded Warrant (right to buy) | |
| John A. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 5,000 | 5,000 | - | - | Stock Option (right to Buy) | |
| Jeffrey S. Ervin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 5,000 | 5,000 | - | - | Stock Option (right to Buy) | |
| Shane J. Schaffer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 57,323 | 57,323 | - | - | Stock Option (right to Buy) | |
| Laurie A. Myers | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 26,056 | 26,056 | - | - | Stock Option (right to Buy) | |
| Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 16,676 | 16,676 | - | - | Stock Option (right to Buy) | |
| Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 16,676 | 16,676 | - | - | Stock Option (right to Buy) | |
| Peter J. Werth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 1,824 | 1,824 | - | - | Stock Option (right to Buy) | |
| Jennifer L. Callahan | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 25,014 | 25,014 | - | - | Stock Option (right to Buy) | |
| Bryan Lawrence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 5,000 | 5,000 | - | - | Stock Option (right to Buy) | |
| J. Werth Peter | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 25 Jan 2024 | 687,043 | 687,043 | - | - | Pre-Funded Warrant (right to buy) | |
| Raul Silva R. | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Peter J. Werth | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 11 Aug 2023 | 1,823,155 | 2,798,320 | - | 0.5 | 1,000,001 | Common Stock |
| Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (right to Buy) | |
| Gregg Wm. Givens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (right to Buy) | |
| Scott Applebaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (right to Buy) | |
| Patrick J. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (right to Buy) | |
| Curtis Medeiros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (right to Buy) | |
| Peter J. Werth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (right to Buy) | |
| Jennifer L. Callahan | Corporate Controller | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 May 2023 | 1,030 | 19,530 | - | - | Warrant to Purchase Common Stock | |
| Jennifer L. Callahan | Corporate Controller | Purchase of securities on an exchange or from another person at price $ 1.08 per share. | 12 May 2023 | 4,000 | 38,508 | - | 1.1 | 4,320 | Common Stock |
| Jennifer L. Callahan | Corporate Controller | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 12 May 2023 | 2,000 | 40,508 | - | 1.0 | 2,020 | Common Stock |
| Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 10,000 | 10,000 | - | - | Stock Option (right to Buy) | |
| Louis Van Horn | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 50,000 | 50,000 | - | - | Stock Option (right to Buy) | |
| Shane J. Schaffer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 90,000 | 90,000 | - | - | Stock Option (right to Buy) | |
| Laurie A. Myers | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 40,000 | 40,000 | - | - | Stock Option (right to Buy) | |
| Craig S. Gilgallon | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 40,000 | 40,000 | - | - | Stock Option (right to Buy) | |
| Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 15,000 | 15,000 | - | - | Stock Option (right to Buy) | |
| Jennifer L. Callahan | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 20,000 | 20,000 | - | - | Stock Option (right to Buy) | |
| Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 16,084 | 16,084 | - | - | Stock Option (right to Buy) | |
| Shane J. Schaffer | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Dec 2022 | 200 | 70,738 | - | - | Warrant to Purchase Common Stock | |
| Shane J. Schaffer | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Dec 2022 | 3,642 | 70,538 | - | - | Warrant to Purchase Common Stock | |
| Shane J. Schaffer | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 15 Dec 2022 | 10,000 | 41,500 | - | 1.0 | 10,166 | Common Stock |
| Jennifer L. Callahan | Corporate Controller | Purchase of securities on an exchange or from another person at price $ 0.99 per share. | 14 Dec 2022 | 7,548 | 34,508 | - | 1.0 | 7,468 | Common Stock |
| Shane J. Schaffer | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 13 Dec 2022 | 1,733 | 18,233 | - | 1.0 | 1,750 | Common Stock |
| Shane J. Schaffer | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 13 Dec 2022 | 13,267 | 31,500 | - | 1.0 | 13,400 | Common Stock |
| Shane J. Schaffer | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Dec 2022 | 396 | 66,896 | - | - | Warrant to Purchase Common Stock | |
| Peter J. Werth | Director | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 13 Dec 2022 | 28,934 | 975,165 | - | 1.0 | 28,422 | Common Stock |
| Jennifer L. Callahan | Corporate Controller | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 28 Nov 2022 | 1,530 | 26,960 | - | 1.0 | 1,499 | Common Stock |
| Jennifer L. Callahan | Corporate Controller | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 28 Nov 2022 | 3,487 | 25,430 | - | 1.0 | 3,417 | Common Stock |
| Laurie A. Myers | EVP and COO | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 23 Nov 2022 | 1,111 | 48,263 | - | 0.9 | 1,000 | Common Stock |
| Craig S. Gilgallon | EVP, GC and Secretary | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 23 Nov 2022 | 3,575 | 9,550 | - | 0.8 | 3,003 | Common Stock |
| Gregg Wm. Givens | Director | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 22 Nov 2022 | 85,000 | 154,318 | - | 0.9 | 74,851 | Common Stock |
| Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 15,032 | 15,032 | - | - | Stock Option (right to Buy) | |
| Jennifer L. Callahan | Corporate Controller | Purchase of securities on an exchange or from another person at price $ 1.50 per share. | 08 Sep 2022 | 3,500 | 21,943 | - | 1.5 | 5,250 | Common Stock |
| Peter J. Werth | Director | Purchase of securities on an exchange or from another person at price $ 1.52 per share. | 06 Sep 2022 | 74,500 | 946,231 | - | 1.5 | 113,225 | Common Stock |
| Laurie A. Myers | EVP and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Sep 2022 | 200 | 47,152 | - | 0 | Common Stock | |
| Laurie A. Myers | EVP and COO | Purchase of securities on an exchange or from another person at price $ 1.57 per share. | 01 Sep 2022 | 636 | 47,352 | - | 1.6 | 999 | Common Stock |
| Scott Applebaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 12,000 | 12,000 | - | - | Stock Option (right to Buy) | |
| Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 11,017 | 11,017 | - | - | Stock Option (right to Buy) | |
| Laurie A. Myers | EVP and COO | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 01 Jun 2022 | 200 | 46,716 | - | 1.2 | 236 | Common Stock |
| Laurie A. Myers | EVP and COO | Purchase of securities on an exchange or from another person at price $ 1.21 per share. | 17 May 2022 | 200 | 46,516 | - | 1.2 | 242 | Common Stock |
| Curtis Medeiros | Director | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 06 May 2022 | 17,532 | 0 | - | 1.3 | 22,208 | Common Stock |
| Peter J. Werth | Director | Purchase of securities on an exchange or from another person at price $ 1.79 per share. | 17 Mar 2022 | 27,000 | 871,731 | - | 1.8 | 48,330 | Common Stock |
| Laurie A. Myers | EVP and COO | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 16 Mar 2022 | 353 | 46,316 | - | 1.4 | 494 | Common Stock |
| Jennifer L. Callahan | Corporate Controller | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Mar 2022 | 16,879 | 18,500 | - | - | Warrant to Purchase Common Stock | |
| Jennifer L. Callahan | Corporate Controller | Purchase of securities on an exchange or from another person at price $ 1.39 per share. | 16 Mar 2022 | 1,900 | 18,443 | - | 1.4 | 2,641 | Common Stock |
| Shane J. Schaffer | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Mar 2022 | 50,000 | 66,500 | - | - | Warrant to Purchase Common Stock | |
| Jennifer L. Callahan | SVP and CFO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Mar 2022 | 1,500 | 21,030 | - | - | Warrant to Purchase Common Stock | |
| Jennifer L. Callahan | SVP and CFO | Purchase of securities on an exchange or from another person at price $ 27.11 per share. | 15 Mar 2022 | 55 | 2,333 | - | 27.1 | 1,491 | Common Stock |
| Gregg Wm. Givens | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 14 Mar 2022 | 6,000 | 6,000 | - | 1.3 | 7,779 | Common Stock |
| Gregg Wm. Givens | Director | Purchase of securities on an exchange or from another person at price $ 1.38 per share. | 14 Mar 2022 | 4,000 | 10,000 | - | 1.4 | 5,520 | Common Stock |
| Gregg Wm. Givens | Director | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 14 Mar 2022 | 4,000 | 10,000 | - | 1.4 | 5,480 | Common Stock |
| Gregg Wm. Givens | Director | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 14 Mar 2022 | 4,000 | 10,000 | - | 1.4 | 5,493 | Common Stock |
| Gregg Wm. Givens | Director | Purchase of securities on an exchange or from another person at price $ 1.38 per share. | 14 Mar 2022 | 27,000 | 69,318 | - | 1.4 | 37,338 | Common Stock |
| Gregg Wm. Givens | Director | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 14 Mar 2022 | 6,000 | 6,000 | - | 1.3 | 7,719 | Common Stock |
| Gregg Wm. Givens | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 14 Mar 2022 | 6,000 | 6,000 | - | 1.3 | 7,790 | Common Stock |
| Gregg Wm. Givens | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 14 Mar 2022 | 9,000 | 42,318 | - | 1.3 | 11,866 | Common Stock |
| Louis Van Horn | EVP and CFO | Purchase of securities on an exchange or from another person at price $ 1.34 per share. | 14 Mar 2022 | 15,000 | 15,000 | - | 1.3 | 20,045 | Common Stock |
| Curtis Medeiros | Director | Purchase of securities on an exchange or from another person at price $ 1.41 per share. | 14 Mar 2022 | 17,532 | 17,532 | - | 1.4 | 24,764 | Common Stock |
| Craig S. Gilgallon | EVP & General Counsel | Purchase of securities on an exchange or from another person at price $ 1.38 per share. | 14 Mar 2022 | 5,975 | 5,975 | - | 1.4 | 8,227 | Common Stock |
| Craig S. Gilgallon | EVP & General Counsel | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Mar 2022 | 5,016 | 5,016 | - | - | Warrant to Purchase Common Stock | |
| Jennifer L. Callahan | Corporate Controller | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Mar 2022 | 1,621 | 1,621 | - | - | Warrant to Purchase Common Stock | |
| Jennifer L. Callahan | Corporate Controller | Purchase of securities on an exchange or from another person at price $ 1.46 per share. | 14 Mar 2022 | 12,000 | 16,543 | - | 1.5 | 17,494 | Common Stock |
| Gregg Wm. Givens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 9,000 | 9,000 | - | - | Stock Option (right to Buy) | |
| Louis Van Horn | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 30,000 | 30,000 | - | - | Stock Option (right to Buy) | |
| Patrick J. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 9,000 | 9,000 | - | - | Stock Option (right to Buy) | |
| Curtis Medeiros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 9,000 | 9,000 | - | - | Stock Option (right to Buy) | |
| Shane J. Schaffer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 67,500 | 67,500 | - | - | Stock Option (right to Buy) | |
| Laurie A. Myers | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 30,000 | 30,000 | - | - | Stock Option (right to Buy) | |
| Craig S. Gilgallon | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 30,000 | 30,000 | - | - | Stock Option (right to Buy) | |
| Raul R. Silva | EVP and Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 6,000 | 6,000 | - | - | Stock Option (right to Buy) | |
| Matthew Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 12,500 | 12,500 | - | - | Stock Option (right to Buy) | |
| Jeff Hargroves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 9,000 | 9,000 | - | - | Stock Option (right to Buy) | |
| Peter J. Werth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 9,000 | 9,000 | - | - | Stock Option (right to Buy) | |
| Jeff Conroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 9,000 | 9,000 | - | - | Stock Option (right to Buy) | |
| Jennifer L. Callahan | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 10,000 | 10,000 | - | - | Stock Option (right to Buy) | |
| Gregg Wm. Givens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 16,500 | 16,500 | - | - | Warrant to Purchase Common Stock | |
| Gregg Wm. Givens | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Dec 2021 | 16,500 | 33,318 | - | - | Common Stock | |
| Shane J. Schaffer | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Dec 2021 | 16,500 | 16,500 | - | - | Common Stock | |
| Shane J. Schaffer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 16,500 | 16,500 | - | - | Warrant to Purchase Common Stock | |
| Jeff Hargroves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 8,300 | 8,300 | - | - | Warrant to Purchase Common Stock | |
| Jeff Hargroves | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Dec 2021 | 8,300 | 8,300 | - | - | Common Stock | |
| Peter J. Werth | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Dec 2021 | 8,300 | 844,731 | - | - | Common Stock | |
| Peter J. Werth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 8,300 | 8,300 | - | - | Warrant to Purchase Common Stock | |
| Gregg Wm. Givens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 8,983 | 8,983 | - | - | Stock Option (right to Buy) | |
| Louis Van Horn | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 67,376 | 67,376 | - | - | Stock Option (right to Buy) | |
| Patrick J. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 8,983 | 8,983 | - | - | Stock Option (right to Buy) | |
| Curtis Medeiros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 8,983 | 8,983 | - | - | Stock Option (right to Buy) | |
| Shane J. Schaffer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 179,668 | 179,668 | - | - | Stock Option (right to Buy) | |
| Laurie A. Myers | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 67,376 | 67,376 | - | - | Stock Option (right to Buy) | |
| Craig S. Gilgallon | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 67,376 | 67,376 | - | - | Stock Option (right to Buy) | |
| Raul R. Silva | EVP and Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 4,492 | 4,492 | - | - | Stock Option (right to Buy) | |
| Matthew Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 4,492 | 4,492 | - | - | Stock Option (right to Buy) | |
| Jeff Hargroves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 8,983 | 8,983 | - | - | Stock Option (right | |
| Peter J. Werth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 8,983 | 8,983 | - | - | Stock Option (right to Buy) | |
| Jeff Conroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 8,983 | 8,983 | - | - | Stock Option (right to Buy) | |
| Jennifer L. Callahan | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 22,459 | 22,459 | - | - | Stock Option (right to Buy) |